Finanzwire Finanzwire
Basculer en Français
11384 Companies
253058 Keywords
182715 Articles
138806 Press releases
Headlines Articles Press releases Core One Labs Inc. Remove
  1. Home
  2. Companies
  3. Core One Labs Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 05/06/2023 at 01:25, 3 years 6 months ago

    Core One in Talks with Multiple Companies to Supply Psilocybin

    Logo of Core One Labs Inc.
  • PRESS RELEASE

    published on 05/02/2023 at 02:25, 3 years 6 months ago

    Core One Labs' GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy

    Logo of Core One Labs Inc.
  • PRESS RELEASE

    published on 04/22/2023 at 01:55, 3 years 7 months ago

    Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility

    Logo of Core One Labs Inc.
  • PRESS RELEASE

    published on 01/24/2023 at 18:00, 3 years 9 months ago

    Core One Labs' Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases

    Logo of Core One Labs Inc.
  • PRESS RELEASE

    published on 01/14/2023 at 01:25, 3 years 10 months ago

    Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers

    Logo of Core One Labs Inc.
Previous page
1 2
Accesswire
  • Published on 11/20/2026 at 15:00, 1 day 10 hours ago

    Jaguar Health, Inc. Announces Reverse Stock Split

  • Published on 11/20/2026 at 14:50, 1 day 11 hours ago

    Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture

  • Published on 11/20/2026 at 14:00, 1 day 11 hours ago

    Dateline appoints Tony Ferguson as Acting Chairman

  • Published on 11/20/2026 at 13:30, 1 day 12 hours ago

    Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec

  • Published on 11/20/2026 at 13:30, 1 day 12 hours ago

    Alset AI Closes Non-Brokered Private Placement Offering

View all ACCESSWIRE
EQS Group
  • Published on 11/20/2026 at 23:45, 1 day 2 hours ago

    APEC CEO Summit 2026 Concludes Successfully in Shenzhen

  • Published on 11/20/2026 at 22:36, 1 day 3 hours ago

    Abivax Statement on Short Seller Report

  • Published on 11/20/2026 at 21:36, 1 day 4 hours ago

    EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders

  • Published on 11/20/2026 at 19:26, 1 day 6 hours ago

    EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack

  • Published on 11/20/2026 at 19:03, 1 day 6 hours ago

    EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group

View all EQS
Les Echos
  • Published on 11/20/2026 at 18:34, 1 day 7 hours ago

    Disclosure of transactions in own shares from November 16 to November 20, 2026

  • Published on 11/20/2026 at 17:35, 1 day 8 hours ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026

  • Published on 11/19/2026 at 19:00, 2 days 6 hours ago

    MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR

  • Published on 11/19/2026 at 08:30, 2 days 17 hours ago

    Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing

  • Published on 11/19/2026 at 08:00, 2 days 17 hours ago

    EXOR TO RAISE ITS STAKE IN BIOMÉRIEUX

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy